Algorae Pharmaceuticals Limited (LVCLF)

Market Cap	20.62M +225.5%
Revenue (ttm)	n/a
Net Income	-676.46K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,990,000
Average Volume	144,732
Open	0.0079
Previous Close	0.0049
Day's Range	0.0079 - 0.0079
52-Week Range	0.0015 - 0.0079
Beta	0.14
RSI	55.50
Earnings Date	Apr 23, 2026

About Algorae Pharmaceuticals

Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company’s product pipeline includes AI-116, a novel combination drug candidate made up of donepezil and cannabidiol for the treatment of dementia, including Alzheimer’s disease; AI-168, a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient for the treatment of cardiovascular disease, such as hypertension; and NTCELL, an alginate...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1987
• Employees: 48
• Stock Exchange: OTCMKTS
• Ticker Symbol: LVCLF

Financial Performance

Financial numbers in AUD